UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Apple
AAPL
|
+$642M |
| 3 |
NVIDIA
NVDA
|
+$626M |
| 4 |
Eli Lilly
LLY
|
+$561M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
+$447M |
Top Sells
| 1 |
Nike
NKE
|
+$1.2B |
| 2 |
Tesla
TSLA
|
+$536M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$274M |
| 4 |
Match Group
MTCH
|
+$261M |
| 5 |
CRH
CRH
|
+$233M |
Sector Composition
| 1 | Technology | 21.74% |
| 2 | Financials | 10.72% |
| 3 | Healthcare | 8.29% |
| 4 | Consumer Discretionary | 6.93% |
| 5 | Communication Services | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Nuveen Preferred & Income Opportunities Fund
JPC
$2.65B
| $32.4M | 0.01% |
4,010,312
+473,948
| +13% | +$3.82M |
|
1027
Charles River Laboratories
CRL
$7.86B
| $32.3M | 0.01% |
163,916
+17,474
| +12% | +$3.44M |
|
|
TBLD
1028
Thornburg Income Builder Opportunities Trust
TBLD
$651M
| $32.1M | 0.01% |
1,800,644
+178,070
| +11% | +$3.17M |
|
1029
Avantor
AVTR
$8.87B
| $32M | 0.01% |
1,237,150
+167,573
| +16% | +$4.34M |
|
1030
iShares Morningstar Mid-Cap Growth ETF
IMCG
$2.95B
| $32M | 0.01% |
438,489
-79,625
| -15% | -$5.81M |
|
|
IBTE
1031
DELISTED
iShares iBonds Dec 2024 Term Treasury ETF
IBTE
| $31.9M | 0.01% |
1,328,892
-615,271
| -32% | -$14.8M |
|
1032
Universal Health Services
UHS
$12.1B
| $31.9M | 0.01% |
139,175
+46,926
| +51% | +$10.7M |
|
1033
Ralph Lauren
RL
$19.2B
| $31.9M | 0.01% |
164,326
+36,134
| +28% | +$7.01M |
|
1034
JB Hunt Transport Services
JBHT
$13.7B
| $31.8M | 0.01% |
184,783
+31,051
| +20% | +$5.35M |
|
1035
CyberArk
CYBR
$23.8B
| $31.8M | 0.01% |
109,140
+15,904
| +17% | +$4.64M |
|
1036
Donaldson
DCI
$9.51B
| $31.8M | 0.01% |
431,370
+34,582
| +9% | +$2.55M |
|
1037
Ovintiv
OVV
$10.9B
| $31.7M | 0.01% |
828,458
+284,270
| +52% | +$10.9M |
|
1038
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.43B
| $31.7M | 0.01% |
343,186
-8,728
| -2% | -$807K |
|
1039
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.28B
| $31.7M | 0.01% |
1,756,298
-330,143
| -16% | -$5.96M |
|
|
AXNX
1040
DELISTED
Axonics, Inc. Common Stock
AXNX
| $31.7M | 0.01% |
455,206
+161,621
| +55% | +$11.2M |
|
1041
CRISPR Therapeutics
CRSP
$5.08B
| $31.6M | 0.01% |
673,588
+249,372
| +59% | +$11.7M |
|
1042
iShares US Consumer Staples ETF
IYK
$1.34B
| $31.6M | 0.01% |
447,872
-3,545
| -0.8% | -$250K |
|
1043
Gen Digital
GEN
$18.3B
| $31.5M | 0.01% |
1,149,320
+199,449
| +21% | +$5.47M |
|
1044
Vanguard Emerging Markets Government Bond ETF
VWOB
$4.61B
| $31.4M | 0.01% |
473,083
-44,805
| -9% | -$2.97M |
|
1045
MarketAxess Holdings
MKTX
$7.04B
| $31.3M | 0.01% |
122,076
+15,258
| +14% | +$3.91M |
|
1046
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$1.9B
| $31.2M | 0.01% |
412,384
-68,980
| -14% | -$5.23M |
|
1047
Western Alliance Bancorporation
WAL
$9.89B
| $31.2M | 0.01% |
361,131
+147,177
| +69% | +$12.7M |
|
1048
A.O. Smith
AOS
$10.4B
| $31.1M | 0.01% |
346,255
+60,463
| +21% | +$5.43M |
|
1049
USA Compression Partners
USAC
$2.92B
| $31.1M | 0.01% |
1,356,023
+155,504
| +13% | +$3.56M |
|
1050
iShares Global Healthcare ETF
IXJ
$3.89B
| $30.9M | 0.01% |
314,533
+22,822
| +8% | +$2.24M |
|